Momentum Options Trading Blog
Daily market updates at 9am & 1pm EST
Categories
Archives
Blog Roll

Posts Tagged ‘Genentech’

Weekly Wrap for 2/8/09

Sunday, February 8th, 2009

1. Commentary
2. Straddle’s Part 2 (Amazon Keeps on Rolling)
3. Financial Sector (open positions)
4. Akamai Technologies
5. Current Trades
6. Earnings
7. Closing Thoughts

**************************************************

1. Commentary

The market had an outstanding week and it has been a minute since I have said that. For all of the gloom and doom from 2008 that followed us in 2009, it was put aside as the Dow had its biggest week of the year. The Nasdaq and S&P 500 posted better returns but the general public and Wall Street worry more about the health of the Dow.

For the week, the Dow added 280 points and finished at 8,280, or 3.5% higher. The S&P 500 tacked on 43 points and closed at 868, up 5.2%. The big story though is the Nasdaq which zoomed 115 points, or 7.8%, to end the week just shy of 1,600. Yes, Tech is back and the rally helped put the Nasdaq in the green YTD by 0.9%. The Dow is still down 5.6% while he S&P 500 is off by 3.8%.

Cisco Systems (CSCO, $17.04, up $0.69) and Walt Disney (DIS, $19.45, up $0.74) reported earnings and both stocks held up well despite some unsettling news. Cisco managed to beat expectations by six cents but revenues and net income were down. The company also said sales could be down 20% for the current quarter. However, Cisco did say that they expect to grow between 12%-17% a year.

Disney missed on their revenue expectations of $10 million which came in at $9.6 billion, down 9% over the year. The company earned $0.41 while Wall Street had expectations of $0.50. There were other hit and misses on the earnings front and most of the who’s-who has announced.

The rally was uplifting for the bulls and came in the wake of some really crummy unemployment numbers. The number of people losing their jobs continues to rise and hit 600,000 in January, which was the largest monthly loss in over three decades. In case you are wondering, there have been nearly 1.8 million jobs lost in the last three months alone. The unemployment rate stands now stands at 7.6%.

**************************************************

2. Straddle’s Part 2 (Amazon Keeps on Rolling)

Last week in the Weekly Wrap, we talked about using straddles as another way to use options in your trading account. Specifically, I had profiled Amazon.com (AMZN, $66.55, up $3.37) after they announced earnings and how the stock jumped nearly $9 the next day. Amazon added another $8 this week which was huge for the call options I profiled.

The day before Amazon announced, the February 50 calls (ZQNBJ, $16.75, up $3.50) and the February 50 puts (ZQNNJ, $0.16, down $0.08) were at $4.10 and $4.15. I talked about the returns had you closed out just the call side of the trade which would have made 15% in a day.

But if you had left the position open, you are now at a double. The total cost of the trade would have been around $825 ($410 + $415). As it stands now, the total position is worth nearly $1,700 ($1,675 + $16). You would get $1,675 for the calls and $16 for the puts right now.

Amazon piggy-backed the Nasdaq and had a monster week. There are a lot of investors who shy away from playing earnings annuncements and I’ll admit, they are risky. But, if you feel like a stock is going to make a huge move of 10% or more, figure out your profits for the straddle. If it looks too risky for you, then don’t do it.

Not all straddles will work out this well but I wanted to follow-up on the returns they can provide if the stock continues to move in one direction. The beauty is that the calls still have about two more weeks before they expire. You could set a stop of $15 for the calls and then ride the puts all the way to expiration or sell them and get another $15 for each contract.

**************************************************

3. Financial Sector (open positions)

The financial sector put in a good effort and gained 6% for the week led by Friday’s huge gains. There has been on-going talk about what the government is planning to revive the nation’s banks and that topic of conversation picked up steam on Friday.

Word is there is a new “comprehensive” plan that the government is expected to announce on Monday and it will likely be a market mover. The plan is expected to allow select banks to write-off bad mortgage assets,other losses and maybe more even give them more cash. The Senate also met over the weekend to hammer out details on the government-stimulus package that is expected to cost more than $900 billion. Just say a trillion plus and be done with it.

We got into some call options on Friday and kept them open over the weekend. This is always dangerous but some of you may have closed out a portion of your trades to take some money off the table. Nothing wrong with that….

Bank of America (BAC, $6.13, up $1.29)

The February 6 calls (BYOBF, $1.15, up $0.50) traded 110,000 contracts on Friday. The calls opened at 90 cents and traded as low as 80. The high was $1.50. I told you there would be a ton of action in the call options Friday morning. Nimble traders did very well but the rally could continue. BofA was up another $0.25 in after-hours trading.

Goldman Sachs (GS, $96.57, up $3.72)

We entered the February 100 calls (GSBT, $4.00, up $1.20) for under $3 and they traded as high as $4.10. Goldman looked strong for most of the day and got stronger right into the close. Goldman was up another $1.50 in after-hours trading to $98.

JPMorgan (JPM, $27.63, up $3.09)

The February 25 calls (JSABE, $4.00, up $1.90) opened at $2.45 and JP added over 12% for the day. The stock was up another 41 cents in Friday’s extended trading and was above $28.

Visa (V, $55.41, up $1.67)

The February 55 calls (VBK, $2.10, up $0.70) hit a high of $2.15 and were entered the day before earnings at 60 cents. At current levels that is a 250% gain.

The world is still moving to plastic and getting away from cash. Ten years ago, 60% of purchases were done with cash, now it’s the other way around. Visa and Mastercard (MA, $162.50, up $2.66) are the kings of the industry and each had a stellar week.

All of these positions still carry risk but hopefully we can get a higher open on Monday and we will see where we are at. There are no stops listed but you should know by now how the smart money works. Watch the open and manage your positions from there. I’ll give an update first thing Monday morning in the blog.

**************************************************

4. Akamai Technologies

Akamai Technologies (AKAM, $17.41, up $0.68) is suddenly hot again after reporting better-than-expected earnings. The stock added 25% after the company said it earned $0.44 a share which beat expectations by four cents. There were three upgrades to “Buy” this month alone.

I have been covering Akamai since joining OptionsMentoring.com over three years ago but most of the articles are in our article section and not the blog. Of course, back then Akamai was in the $50′s and I was talking about the company’s prospects.

Akamai provides the technology (content-delivery networks or CDNs) used to stream video and multimedia content on the Web. It is by far the Ace of Spades when it comes to the CDN market commanding nearly 70% of the market share. That number may have changed since my last update and is hottly debated but you get the picture.

Akamai has been on both sides of the earnings surprise and had a string of beating earnings estimates up until last year. There’s a fine line between reporting “in-line” numbers and beating expectations and Akamai has been able to hold up well during the economic downturn.

Although the stock can be volatile and is prone to large swings, Akamai’s biggest customers include Apple (AAPL, $99.72, up $3.26), FedEx (FDX, $55.27, up $2.69), Microsoft (MSFT, $19.66, up $0.62), Viacom (VIA, $18.12, up $0.87), and XM Satellite Radio (SIRI, $0.12, down $0.03). Content delivery is an area that is attracting a lot of attention and Akamai is certainly benefitting from Apple’s iPhone and Research in Motion’s smartphones.

This means Akamai will help deliver high-bandwidth online content, like YouTube which you may have seen in Apple’s commercials for the iPhone. Akamai should continue to drive incremental revenues, not like in the past but online sales are still expected to grow 11% in 2009, and over time this will help the bottom line.

As far as Akamai’s top competitors goes, there’s no need to mention it in converstaion. Competition from the likes of Limelight Networks (LLNW, $3.33, up $0.16) and Level 3 Communications (LVLT, $0.99, up $0.07) hasn’t been serious enough to take away major market share.

Think of Akamai dominating the market with its content delivery the way Apple dominates the market when it comes to music and the iPod. The real growth for Akamai will be online video where the market is just beginning. Most videos are still viewed on the TV but the trend is shifting.

When Akamai was in the $50′s, it was richly priced as it carried a price-to-earnings (PE) ratio of 138. That fat was trimmed in 2008 and now the stock has a PE of 22.

So is the company a good investment? From the aforementioned numbers, maybe. But you know I’m not really a stock guy. I’m not sure if the rally can last but keep an eye on the March 17.50 calls (UMUCW, $1.25, up $0.30). If the stock can rally to $20 by March 20th, the calls will be worth at least $2.50. If Akamai continues its rally this week, that target could be hit a lot sooner.

Note: XM Satellite Radio had back-to-back days of huge volume. On Thursday, 157 million shares traded. Friday, 188 million. For a 12 cent stock, it sure has gotten a lot of action. Penny stocks are penny stocks for a reason…stay away by the way.

**************************************************

5. Current Trades

I put the financial trades in a section by themselves because there were four of them and I wanted provide some additional commentary. It’s unusual that I have this many trades open but the financial plays were something we had to take advantage of on Friday. Here are the other options we are tracking.

Amgen (AMGN, $58.03, up $0.92)

The stock added nearly $3 for the week and traded higher every day. Amgen looks poised to break $60 but we already have some monster profits with a the March call options.

The March 60 calls (YAACL, $1.85, up $0.30) were recommended last Tuesday at $1.20 and have returned a little over 50% thus far. We could set stops at $1.80 but this gives us no room to work with in case we start Monday off lower. These calls still have about 6 weeks left so initial stops could be placed at $1.25. If Amgen stalls from here we can move the stop up.

Netflix (NFLX, $37.00, down $0.47)

The stock managed to test $38 for most of the week but faded on Friday as the stock hit a low of $35.72. In the process, our stops were hit.

The March 35 calls (QNQCG, $4.00, down $0.10) were closed out at $3.90. They were profiled two weeks ago at $2.60 so the return was 50%. The March 40 calls (QNQCH, $1.55, down $0.20) had a stop of $1.35 and were entered at 90 cents. We also got 50% on this one as well.

Genentech (DNA, $83.00, up $0.60)

Don’t get me started on this one. The stock basically did nothing all week and I have mentioned that the Roche bid is keeping a lid on the shares. The February 95 calls (DWNBS, $0.05, unchanged) and the March 95 calls (DWNCS, $0.30, down $0.05) are going down the tubes quick. The February 95 call were profiled at 85 cents, and the March 95 call at $1.50 back on January 12. These are the first two losing trades that I have profiled this year.

The good news is that the call options haven’t expired yet, so there is hope. Albeit, slim and none. If Genentech rejects the offer which I believe they will, then we could get the rally we have all been waiting for. If, and that’s a big if, the stock can make it to $100 a share, the March calls would be worth $5 which would offset the losses in the February calls. So there was protection from the original write-up but I didn’t plan for things to go this way. That is why I recommended both options because the history between these two hasn’t always been peachy.

Google (GOOG, $371.28, up $17.56)

Last Monday, I mentioned that the action in Google was heating up as the company was set to give an update on Google Earth. The February 370 calls (GGDBN, $12.20, up $7.80) were profiled at $2.30 and I thought it would only be good for a one of two day trade. Man, was wrong on that one but sometimes in this game you get lucky. The return on this trade is at 430% if you rode it higher. Talk about lightning in a bottle…

The stock made a $30 move for the week and these out-the-money calls are now in-the-money but look at how much premium is built in the stock. In others words, if Google stayed flat from here on out until February 20, these options will technically only be worth $1.28. So there is over $10 in premium built into these call options. Set stops at $10. Otherwise, ride Sally ride…

Spider Gold Shares (GLD, $89.59, down $0.53)

The ETF (exchange-traded fund) traded lower for most of the day and I lowered the entry prices for the March 99 calls (GLDCU, $1.85, down $0.20) and the March 100 calls (GLDCV, $1.65, down $0.20).

These positions were slightly positive until Friday. We got into the March 99 calls at $2.05 and the March 100 calls at $1.90. Both positions were slightly positive until the ETF slipped back under $90. Set stops at half the entry level prices.

**************************************************

6. Earnings

Monday: Beazer Homes (BZH, $1.00, up $0.12), Hasbro (HAS, $23.54, up $0.22), Infinity Pharmaceuticals (INFI, $8.19, down $0.04), Lions Gate Entertainment (LGF, $5.50, up $0.05), Rohm and Haas (ROH, $56.50, up $1.73) and SOHU.com (SOHU, $45.61, up $2.73).

Tuesday: Applied Materials (AMAT, $10.45, up $0.22), Bob Evans Farms (BOBE, $20.50, up $1.26), Coventry Health Care (CVH, $16.64, up $0.30), Genworth Financial (GNW, $2.32, down $0.02), The DIRECTV Group (DTV, $22.58, up $0.06) and UBS (UBS, $11.20, down $0.20).

Wednesday: Activision Blizzard (ATVI, $9.96, up $0.23), Buffalo Wild Wings (BWLD, $22.67, up $0.66), Chipotle Mexican Grill (CMG, $51.31, down $0.22), Dean Foods (DF, $19.66, up $0.11), iRobot (IRBT, $7.93, up $0.02) and Toll Brothers (TOL, $19.88, up $1.69).

Thursday: Coinstar (CSTR, $24.84, up $0.78), McAfee (MFE, $30.13, up $0.15), Panera Bread (PNRA, $47.54, up $0.23), Rio Tinto (RTP, $121.36, up $12.34, ValueClick (VCLK, $7.00, up $0.11), Viacom (VIA, $18.12, up $0.87) and Waste Management (WMI, $29.75, up $0.27).

Friday: Abercrombie & Fitch (ANF, $20.96, up $0.98) and Pepsico (PEP, $53.53, up $1.18).

There are a couple of names to keep an eye on in this group. There could be some huge winners (or losers) in the bunch and the others will hold keys to certain sectors. We are well represented with a diverse group of stocks that will provide us details on what their company’s earnings will be and what the future holds.

I list the earnings so that if you have any exposure to these stocks, you can plan accordingly. Most of the notable names have already been heard from but there will still be some movers and shakers.

Chipotle Mexican Grill has been a favorite of ours in the past and Panera Bread will likley move a few points this week. I’m surprised that somebody hasn’t scopped up ValueClick in an acquisition yet. Perhaps in 2009? UBS is not you and us anymore. Rohm and Haas is in a battle with Dow Chemical (DOW, $10.88, down $0.03) after Dow pulled out of a merger agreement. It’s in court and it could get ugly.

**************************************************

7. Closing Thoughts

The Nasdaq was impressive last week and was led higher by Apple, Google and Research in Motion (RIMM, $59.17, up $2.37) and is now positive for the year. So does the rally continue? The first hurdle the index must clear is 1,650. If that level is taken down this week, then the next target would be 1780ish. That would be another 10% from current levels.

The Dow will face resistance at 8,375 and 8,500 and the big test will come at 9,000. For the S&P 500, resistance awaits at 930 and some at 950. The mini-mountain it needs to climb is 1,000.

The next few days will gives us big clues on where the market is headed but it would take an act of Congress (no pun intended) to say we are on ur way to a full-fledged rally. We are still in some obvious trading patterns but bulls are eyeing higher ground while the bears aren’t quite ready for hibernation.

The longer the battle which is what we have been locked in, the greater the chance for a serious move in one direction or another. I ain’t Dwayne Wayne but here’s What’s Happening (that quote was courtesy of Kid Rock), watch what the market does when these two huge announcements by the government come out. Digest what is going on and think outside-the-box instead of following the herd. There will be clues on our next trades on which ones will be looking good and which ones won’t.

Rick Rouse
Rick@OptionsMentoring.com

Note: Send me an email if you got the newsletter this week, please. We are testing our sign-up list and we wanted to make sure you got the Weekly in a timely fashion. I won’t be able to answer all of the emails but I do read them all. Send me your thoughts, comments, or questions on what you would like to see in the Weekly.

Also, I’ve had a lot of demand to create a “track record” for the options I mention in the blog. If you’ll notice, I am trying to make the blog to where you learn as go. If you are new to options and new to trading, check it out. I’m researching everything I wrote about in 2008 and there are some juicy tidbits I will be sharing with you over the next few weeks. Like the analysts who were calling for gold to run to $1,500-$2,000 by May 2009. I’ll also bring you the trades from 2008 with a percentage rating.

Wednesday Morning Update

Wednesday, February 4th, 2009

Here’s a look at what we got going on this morning…

The market is in positive territory as BMad is back in the news today. You know, Bernard Madoff, the dude that milked investors for $50 billion in the world’s greatest Ponzi scheme. Bernie told the courts today that he had feared for his physical safety. What gives him that strange idea?

You can bet some more heads are going to roll the more Harry Markopolos continues to talk to Congress. He had some harsh words about the SEC (Securities and Exchange Commission) when he said they failed to act despite receiving credible allegations of fraud from him about Madoff’s operations.

I don’t really talk about this stuff but some of the things that are going on with people and their money simply blow my mind. This is why I like to manage my own money and make my own choices when it comes to investing or trading.

And on that note…

Amgen (AMGN, $57.75, up $1.09) is up another 2% and that means more good news for our call options. I mentioned the February 60 calls (YAABL, $0.80, up $0.25) at 40 cents and the March 60 calls (YAACL, $1.80, up $0.30) were at $1.20. I did favor the March calls more than the Feb’s but both options have already posted great returns. The February calls are up 100% and the March calls are up 50%…

For those of you who didn’t see it coming…Electronic Arts (ERTS, $17.52, up $2.02) was the bus driver for those of you still holding the February 15 puts (EZQNC, $0.20, down $0.70). I warned you…

The Visa (V, $50.55, up $0.58) February 55 calls (VBK, $0.90, up $0.30) dropped like a rock after I mentioned them for a half-position trade at $1.00. Many of you got in for under 75 cents judging from the emails I have received and yes, earnings are due out today after the bell. Once again, if you already have a profit before the market closes, you can close the position and take all of the risk out of the trade. This was a half position so I’d leave it open if you like to roll the dice every once in a while.

Genentech (DNA, $82.19, down $0.78)…let the hate mail begin. I can’t explain it, really. Sorry bubba, it ain’t looking good for the February 95 calls (DWNBS, $0.07, down $0.03) and this will probably the first negative trade of the year.

On the other hand, let the love mail begin for the Google (GOOG, $351.93, up $11.48) February 370 calls (GGDBN, $4.90, up $2.80) which have officially doubled from when they were profiled at $2.30 on Monday. Close the trade or set stops at $4.60.

We are hanging in there with the Spider Gold Shares (GLD, $89.09, up $0.62). The dollar continues to weaken but we are not getting the pop in Gold like we should.

Rick Rouse
Rick@OptionsMentoring.com

Biotech Grumblings

Tuesday, February 3rd, 2009

Genentech (DNA, $82.10, up $0.86) came out with some great news yesterday after the bell and said a late-stage study combining Avastin with Tarceva to treat lung cancer was a huge success. Tarceva is a drug from OSI Pharmaceutical’s (OSIP, $36.39, up $0.79) pipeline and is marketed by Genentech. The two drugs were used as treatment for patients with “advanced nonsmall cell” lung cancer.

The phase 3 trial was stopped early following the recommendation of an independent data safety monitoring board and they could be taking this thing to the FDA real soon. Both stocks got a lift in after-hours, Genentech was up another 90 cents but OSI was up 11%, or $4.04, to $40.43.

The reason OSI Pharmaceutical get more of a pop is because of the whole Genentech/Roche garbage. Roche’s new bid has put a lid on shares and if Genentech would have gotten the pop like OSI did, the stock would be in the low $90′s. No matter how good of a trader you are or how much you study a trade that looks “money”, the market can throw you a curveball.

The OSI call options will get a huge boost on Tuesday. Watch the February 40 calls (GHUBH, $1.00, up $0.50) which had huge volume yesterday and the February 45 calls (GHUBI, $0.15, up $0.06) which traded over 4x its open interest. The clue here during the day was how much the February 40 call options jumped compared to the stock move. The stock was up 2% but that shouldn’t warrent a $4 out-of-the-money call to jump 50%. The February 40 call options could open up anywhere from $2-$3 if the gains hold.

DO NOT chase these calls or trade them, I just want to show you how much they are going to pop this morning.

Genentech is getting a raw deal and maybe the tide will start to turn with this huge announcement. There’s just too much momentum behind the company for the market to ignore. Roche is throwing the baby out with the bath water in its attempt to get Genentech on the cheap. Hopefully, the market will see this and start rewarding Genentech with the premium it deserves.

Elsewhere, there was heavy trading in Amgen’s (AMGN, $55.36, up $0.51) call options. The February 60 calls (YAABL, $0.39, up $0.16) traded over 4,000 contracts and the March 60 calls (YAACL, $1.21, up $0.14) traded over 1,800. There’s talk that Amgen could be a takeover target.

I like the March 60 calls more than the February’s because they allow much more time for not much more premium. In other words, I get an extra 4 weeks for the stock to move past $60 for 80 cents. If the stock gets anywhere near $60 it should have the strength to challenge its 52-week high of $66.51. If you are going to swing for the fences, swing big baby.

Biotech has been hot and time will tell if it gets “white” hot. It’s been frustrating to watch the events with Genentech because things are happening that should have pushed the stock to over $100.

Rick Rouse
Rick@OptionsMentoring.com

Roche Goes Hostile

Friday, January 30th, 2009

Roche threw us a curveball this morning and took its bid for Genentech (DNA, $80.95, down $3.14) directly to the shareholders. The company is now offering about $42 billion, or $86.50 a share for Genentech which is $2.50 less than the offer it made last July. Hogwash.

Roche’s attempt to get Genentech at a lower bid is another slap in the face to its shareholders and although Genentech has not made any comments, this camp says Genentech again holds out for more. One top 10 Genentech shareholder is already rebuffing Roche’s new bid and I don’t believe other shareholders will tender the offer either.

From the head brass at Roche: “We are disappointed that the discussions over the last six months between Roche and the special committee of Genentech have not produced a negotiated agreement. We feel it is now time to give the Genentech minority shareholders the opportunity to decide on our offer. Especially in the current market environment the offer provides an opportunity for all public shareholders to achieve liquidity and to receive a fair price for all their shares.”

Fair price? Geez. If Roche offered $89 back in July, why then, the lower offer? Genentech expects to report results in mid-April for its Avastin colon cancer trial, in addition to pending FDA decisions to expand the drug’s use. Roche is trying to get the rest of the company it does not own before that data is released.

We will have to see how this plays out but continue to hold the the February 95 calls (DWNBS, $0.05, down $0.15) and the March 95 calls (DWNCS, $0.25, down $0.35). These positions got hammered today as a result of the lower bid.

I’ll be back over the weekend to provide an update in the Weekly Wrap.

Rick Rouse
Rick@OptionsMentoring.com

Weekly Wrap 1/25/09

Sunday, January 25th, 2009

1. Commentary
2. Financials
3. Techs
4. Biotechs
5. Earnings
6. Closing Thoughts

**************************************************
1. Commentary

The market continued its slide as the all three major indexes lost ground again last week. There was strength in certain sectors while other sectors continued their volatile ways, especially the financial stocks. The bulls have been unable to put together any kind of winning streak and when they do, it seems the bears are jumping back in and taking the market lower.

For the week, the Dow lost 203 points to finish at 8077, down 2.5%. For the year, the Dow is down 8%. The S&P 500 fell 18 points, or 2.1%, and closed at 831 bringing it YTD loss to 7.9%. The Nasdaq dropped 52 points and settled at 1477, down 3.4% for the week and 6.3% YTD.

The financial sector tanked another 7% last week and can be attributed to the wild girations we are still getting in the market. It was more bad news from the sector and it will be a relief when they are able to get clear their balance sheets of all the bad assets. The problem is that right now, nobody knows what “fair value” is although we should get a clearer picture over the next 90 days. If the situation improves, we can thank the new administration later.

The financial sector will again be in the spotlight this coming week. There are a slew of financial companies reporting earnings as over 125 companies in the S&P 500 will be stepping up to the plate. Add the FOMC meeting on Wednesday, toss in a few lousy economic reports that are likely to come, and we have the makings of another busy week.

**************************************************

2. Financials

The banking stocks continued to make negative news as a number of them reported crappy earnings. There was some drama as well. Bank of America (BAC, $6.24, up $0.53) has lost over half its value since the start of the year and now trades on the single-digits. The stock rallied nearly 10% on Friday, but lost 13% for the week, making it the Dow’s second worst performer.

Merrill Lynch’s CEO John Thain got the ax but not before he paid out $4 billion in bonuses while at the same time reporting $15 billion more in losses to Bank of America. It is clear that BofA overpaid for Merrill and it was clear Thain overpaid on his $35,000 “commode with legs” and his $87,000 area rug in his plush new position with the company…

Capital One (COF, $19.32, down $2.62) shares tanked more than 10% after reporting it had to write-off another billion for bad loans and posted a worse-than-expected loss for the quarter. There were a number of analysts who cut their price target on the stock and lowered their rating. On Thursday, when Capital One missed earnings, they also said more credit losses are on the way. Not good.

The Capital One February 17.50 puts (COFNW, $1.60, down $0.15) actually lost 10% because they were so inflated as far as pricing goes. Over 13,000 contracts traded hands but they did trade to a high of $3 when the stock hit a low of $16.91 on Friday. Further out, bearish traders are also targeting the March 15 puts (COFOC, $1.50 ,down $0.05). If the stock is at $12 by March 20, 2009 these puts will double in value and will be worth at least $3 by expiration. Hmmm…

American Express (AXP, $16.00, down $0.06) also hit a fresh 52-week low of $14.72. Amazing. AmEx used to be a $50 stock. The company reports earnings after the market closes on Monday. Those who are bullish on American Express, see Capital One’s results.

Of course, we caught a little bit of the downside action in financials when HSBC Holdings (HBC, $35.65, down $1.15) hit a low of $33.48. We were all over this one a couple of weeks ago and the trades turned out to be huge winners.

From Tuesday’s blog 1/20/09:

HSBC Holdings (HBC, $33.84, down $6.11) is getting crushed again this morning on more concerns about the European banks. If you thought it was bad over here, it’s worse in Europe. There are a slew of banks that are under serious selling pressure and the fall is stunning.

The February 45 puts (HBCNI, $11.70, up $5.30) were profiled last Tuesday (1/13/09) at $3. At $12, it’s a 300% return. Our stop was at $6.50 and these calls closed at $6.40 on Friday. Sometimes, it’s just the nature of the beast.

The March 45 puts (HBCOI, $12.60, up $4.35) are up another 50% from an entry price of $4.75 and stops were set at $8. The puts closed at $8.25 which was higher than our stop but the stop was still triggered.

The March 40 puts (HBCOH, $8.85, up $3.55) are up an additional 65% from an entry price of $2.75. Stops were set at $5 and the previous close was $5.30.

The March 35 puts (HBCOG, $5.50, up $2.00) are up 60% from an entry price of $1.70. I had set a stop of $3 for them and as luck would have it, that was hit as well. –

So are there any names we can trust? Maybe. Goldman Sachs (GS, $74.91, up $3.88), and JPMorgan (JPM, $24.28, up $1.18) got it when they switched over to a bank holding company but who knows what these two stocks are really worth?

There will be an opportunity to trade these stocks and we may be able to make a little money trading the options but the premiums are jacked-up in both of these names because of the volatility. These are the two companies that are going to be around no matter what happens to Citigroup ($3.47, up $0.36) or Bank of America.

**************************************************

3. Techs

It was the the good, bad and ugly with Tech this week. The Good?
Apple (AAPL, $88.36, unchanged) International Business Machines (IBM, $89.49, down $0.58) and Google (GOOG, $324.70, up $18.20). The bad was eBay’s (EBAY, $12.00, up $0.33) 15% revenue drop and the ugly was the Microsoft (MSFT, $17.20, up $0.09) debacle.

Apple, IBM, and Google had good quarters by Wall Street’s standards. eBay’s numbers slipped and Microsoft dropped a bomb on Wall Street when they missed earnings by two cents AND announced them before the market opened and not after.

The best out of the bunch might be IBM which beat earnings by 25 cents and provided some decent quidance. The stock jumped $10 from $81 to $91 on Tuesday and held up strong the rest of the week. The February 95 calls (IBMBS, $1.15, down $0.25) look like a good trade this week but I wouldn’t buy them until after the market is open at least 30 minutes on Monday.

There is resistance at $93 for the stock which could mean the limit for this trade but if IBM can get past this level, it could clear the way to a move back towards $100.

**************************************************

4. Biotechs

There’s alot happening with Pharma and Bio right now. Pfizer (PFE, $17.45, up $0.24) is closing in on a deal to buy Wyeth (WYE, $43.74, up $4.91) for $67 billion that could “reshape the global drug industry”.

Pfizer will pay shareholders about $50 a share for Wyeth ($33 in cash and 0.985 of a share of Pfizer) as it attempts to address concerns over its ability to offset upcoming patent expirations. Pfizer has a number of drugs that facing expiration, including its blockbuster drug Lipitor, and the deal is crucial to Pfizer.

The two companies spent Sunday hammering out that exchange ratio and other final terms of the deal but that is the jist of it. Pfizer, also expects to raise $25 billion to help fund the deal, with help from Bank of America, JP Morgan and Goldman Sachs.

The other news I want to talk about is Genentech (DNA, $84.30, up $2.60).

Roche still has an $89/share bid on the table from last summer but there has been speculation that a higher bid is coming. There are many analysts that believe a new bid from Roche could push the shares closer to $100 and there may be pressure on Roche to speed things up.

Genentech expects to report results in mid-April in its Avastin colon cancer trial, in addition to pending FDA decisions to expand the drug’s use. The stock had a good day on Friday but drifted lower during the week and is still trading lower than where it was a week ago.

The February 95 calls (DWNBS, $0.40, up $0.20) were entered at 85 cents and the March 95 calls (DWNCS, $0.95, up $0.25) were profiled at $1.50. As you can see, these options are out-of-the-money and have lost 30%-50% of their value from their entry price. I had lifted the stops on these call options because I do believe a deal is forthcoming. However, if Genentech’s stock price doesn’t move much this week, you may want to sell the February calls.

**************************************************

5. Earnings

Monday: Amercian Express, Caterpillar (CAT, $35.66, down $1.57), Freeport-McMoRan Copper & Gold ($22.81, up $0.25), Halliburton Company (HAL, $18.25, up $1.40), McDonald’s (MCD, $58.02, down $0.70), and Texas Instruments (TXI, $24.21, up $0.36).

Tuesday: Bristol-Myers Squibb (BMY, $22.39, up $0.04), DuPont (DD, $24.16, up $0.24), Gilead Sciences (GILD, $48.25, down $0.45), Valero Energy (VLO, $24.59, up $1.29), and Verizon (VZ, $30.44, up $0.28)

Wednesday: AT&T (T, $26.12, up $0.61), ConocoPhillips (COP, $48.18, down $0.09), Flextronics (FLEX, $2.56, down $0.07), Pfizer, Starbucks (SBUX, $9.08, down $0.04), and Wells Fargo (WFC, $15.87, up $0.08).

Thursday: Altria Group (MO, $$16.84, down $0.12), Amazon.com (AMZN, $50.63, up $0.69), Ford Motor (F, $1.80, down $0.14), Rambus (RMBS, $8.81, up $0.46), Raytheon (RTN, $50.38, down $1.16), and Under Armour (UA, $18.77, down $0.60).

Friday: Chevron (CVX, $70.82, up $0.87), Honeywell (HON, $32.21, up $0.24), and Procter & Gamble (PG, $56.00, down $0.96).

**************************************************

6. Closing Thoughts

I have been mentioning the key support levels and I hate to sound like a broken record but they are important. The Dow has been trading between 8000 and 9000 since the November low of 7392. This has provided support for the market but it appears the bears are trying to take the Dow down to a new trading level. That level could be 7400-8000 or it could be even lower. Then again, the market is due for a rally.

The bulls are banking on the stimulus package to help the market while the bears simply don’t believe the plan will work. We’ve been in this tight range for three months now and pretty soon we should know what the next leg of the market is going to be. In the meantime, we have used both call and put options in the current market with tight stops and one foot already out the door.

In markets like this, we may leave some profits on the table but that’s okay. I’d rather walk away with a 100% return than risk having to give some of those profits back. The market remains volatile which has helped make us mad money in two or three trading sessions. That trend should continue this week and if some of these trades happen to jump 50% or more, there is nothing wrong with closing them out. Of course, I’ll be here throughout the week with updates.

Rick Rouse
Rick@OptionsMentoring.com

« Older Entries Newer Entries »
2012 Closed Trades:
    Our updated 2012 Track Record is now at 85-18 for an 82% win rate. We have closed 24-straight winning option trades since late March!

    Despite the recent volatility, we have given more "locks" to our subscribers than a Vegas bookie. If you started with a $10,000 trading account, our CLOSED option picks would have made you over 600% by now. In other words, YOUR $10,000 option trading account would be worth over $70,000 as we have become one of the most powerful option newsletters in the business. Our biggest trade of the year so far was hit in early May when shares of Green Mountain Coffee Roasters (GMCR) fell 50% after an earnings miss which made our subscribers 576% on the put options!

    We DON"T count "half" closed trades twice, or "third" closed trades three times like other option newsletters do. Some option services will fluff their Track Records up by using these smoke-and-mirror tricks. They will also "average down" a losing trade in hopes of it coming back then will record the "average" price of the trade when it was really 2 bad trades. Most option websites DON'T have track records and say they give 300% winners. The devil is in the details.

    We don't play these types of games which is why we have the most dedicated subscribers in the business because we have earned their trust. We have recommended 103 trades, 85 winners, 18 losers for 2012. Pretty simple and pretty powerful. We also have verified auto-trading partners who trade our recommendations for your account if you cannot watch the market. They will also tell you how good and how honest our service is.

    Here are some of our other profitable triple-digit recommendations: Capital One (COF) call options +423% in 8 days, American Express (AXP) call options +310% in under 7 days, magicJack (CALL) call options +80% in 3 days, Microsoft (MSFT) call options +124%, STX call options +100% in 2 weeks, +114% and +131% on 2 MGM Resorts (MGM) call options trades in 3 weeks, +158% on Zynga (ZNGA) call options and +107% in Aflac (AFL) call options in 6 days. We also had a +200% winner with Scientific Games (SGMS). Some of our double-digit gains include +58% on WPRT calls, +80% on TSM and +38% on INT call options.

    Our Weekly Wrap is 35-0 since the start of 2011 and is 17-0 for 2012. Some of our winners include +55% on Solazyme (SZYM), +27% on Clean Energy Fuels (CLNE), +38% on Vivus (VVUS), +17% on MGM, +18% on Dendreon (DNDN), and +20% on Darling (DAR). Despite what the suit-and-ties say, you can make incredible gains trading the RIGHT covered calls.

    Over the past 5 years we are averaging a 75% winning percentage for all our trades despite volatile, flat and choppy markets. Come see why some of Wall Street's pros are following us instead of the Journal!

    Here are some of our profitable 2011 recommendations: ORLY call options +191%, VMW call options +100%, JOYG call options +169%; GS put options +184%; FDX put options +164%; OXY put options +74%; +137% on RIMM put options, +1,167% on RMBS puts in 11 days, +296% on FCX calls; +157% on ZAGG calls; +110% on LNKD puts; +133% on RLD put options.

    You can also request our Track Records to see all years by entering your email address which will allow you access to the portfolios.

    If you are missing these juicy profits, come give us a try. Get your password to our Members Area instantly when you sign up TODAY! One profitable trade will easily pay for your membership. You can request our 2008-2011 Track Records by sending us an email or filling out the box below. 665 Total Trades; 459 WINNERS or 7-out-of-10.


2008 - 2010
Track Record
94.05%
73% winners
Results are NOT compounded.

Request our detailed Track Records which are updated in our Members Area. As soon as you sign-up for a subsciption, you will have access to all open and closed trades for 2011 and past years.

Enter Your Email Address:

Trader Comments:

    REGINA L.
    I just want you to know that I love the way you write and explain everything. I am new to this, and have lost 50% of my account until I met you guys. Iit is slowly coming back. I will be calling to set up a year
    of membership rather than the one quarter. Thanks again, and LOVE YOU ALL.

    STEVE T.
    Rick, I appreciate the advice. I think I will just sit back and utilize your selections only for awhile. This will obviously save me a great deal of money in commissions. I have gone thru your entire site including the video on money management. This has brought me to the stark realization that I have been trading too much for too little. I definitely have not been "swinging for the fences", but I also think I have been getting impatient with trades and getting out too fast. This has no doubt caused me too trade too much. I like, and definitely agree on, the advice on money management. Thanks for the help.

    SCOTT H.
    Thank you!!! I held on to the NFLX position since Nov. 13 at a cost of $1.89. Sold ½ on April 14th for a 540% return and the other ½ upon earnings for 702% return. Total profit of $11,615 a 621% return. Keep the recommendations coming and thanks to you and your team for the service you provide.

    PETER G.
    Rick & Team, GREAT Call on NKE for my two trading accounts:
    1) Entry at .65, out at 1.45, 1.55 Profit = $415
    2) Entry at .60, out at 1.75, 1.50 Profit = $485

    LAWRENCE O.
    Hey Rick! Here is an update on what your picks have done in my accounts.

    1) Great call on the JoyG March 55. I bought when you said, then bought again on one of the dips. Booked 80+% profit. Made enough to pay for your service for years to come.

    2) Also booked profits on your Berk Feb 74 (80%) and threw a major chunk of change at the March 75’s (190+%). I would have never known that Buffet's stock had split if it weren’t for your service. Bought the shares also for the long haul. Won’t look at them for another 20 years. Great job on getting us in before the indexes did.

    3) Took profit on your Imax March 12.5. 20 cent trailing stop at 1.90 yesterday. Not sure what the profit on that was, but profit is profit.

    I see that you took a loss on some of these. It’s all good. I look to trade your “ideas” not your exact calls. I THANK YOU! For your ideas and commentary. Keep up the good work. And keep those ideas coming.

    C.J.
    Loving this subscription so far! I got into the BRK feb 76 calls the day you talked about right before the split...now up over 300% (0.70 to 2.475)! Keep the good picks coming and let's see some OSIS and EMC upside soon! Just wanted to share my positive enthusiasm on your newsletter...it gives us individual investors great ideas on not only the options market, but also the broader equity market! Case in point is BRK...I can't always read the breaking business news but its easy to read your twice daily updates on my smartphone...helped me get some BRK shares immediately after the split which I will hold for the long haul! Thanks again!

    SHAUN
    Aloha Rick - Thank you so much for the great CL pick. I am not sure if there was buy-out/merger news or what but at 3PM today Colgate-Palmolive absolutely EXPLODED to the upside, and my calls turned into green candy when they went from 1.40 to 3.8 in a matter of seconds! I even sold a few for over 4.0! Much thanks and keep the solid picks up my friend, honestly. Only a fool would scoff at 267% gains... Peace!

    MICHAEL K.
    I like the fact that you ask for comments from subscribers. Good customer service. By the way, am enjoying the service so far. Some good
    profitable calls. Keep up the good work.

    PARAG P.
    Woo hoo! Out for 50% on WMT this am. Making up for my depression for getting out of pcln for a 30% gain monday :( you the man! any word on the manual? My friend Mike ( who I sent to your service) told me he emailed you about your integrity in reporting fills. I echo that sentiment big time.. keep it up! Cheers!

    JAY P.
    Hi Rick, as a new member all I can say is, 'show off' LOL, with PCLN.

    MIKE
    Rick, I am a new subscriber to your service, and I want to say I am impressed. I am impressed by your results, but more than that I am impressed by your reporting of your fills. You could have easily said you got that Wal-Mart call today for 80 cents, instead you reported 98 cents! Good job and keep it up, I watched the reporting of the fills first, and then I subscribed. Thank You.

    TRISH D.
    Hi, good morning. I jumped the gun a little on this one (PCLN). But still made $1,675.00 profit!! Very happy!! Keep up the good work!! Thanks.

    MIN L.
    Hi there, I have joined recently, and I am very happy to tell you that I am up over $10,000 on your picks in a month. I started on 10/7 with the Intel pick. I'll be your member for life. Please don't quit on us. Also, I am learning a lot about options. I didn’t get in your recent APOL and that gold trade and only had one loss on CHK. I appreciate all the DD you do. I enjoy your market commentaries. Best advice site period, and I have tried a few here and there. Again, you guys rock!

    JOE G.
    Thanks be to Momentum Options Trading for providing me with some fantastic wins. I just started with this service and am up nearly 50% in less than a month. There have been losses, but if I manage them properly, I will continue the best efforts given on the blog (in which there are no complaints). What a great cause for humanity. I feel more confident about my trades and continue to play the wins. Best of all, I am now keeping my regular paychecks in the bank! Thank you!

    GREG F.
    Rick - I wanted to say thanks for getting me started on the right foot with your service. I have made six trades since starting on October 22, 2009. Five are winners and One loser netting me $6,245. Thanks again and keep the trade recommendations coming.

    NOEL
    I got into the Nike 60 Call at 1.85, sold at 5.00, also bought a 55 put at 1.05, but got stopped out at .35. What a ride! $2830.00 in the black even with the put. It's right at 100% return. I hope earnings season coming up is going to look like this trade.

    TODD F.
    Nice call on Nike. I think I'll go buy a pair with my profits! : ) I did the straddle for safety but still made 62% on the trade. Not bad for less than 24 hours. If Goldman is right, then the Nov 70s or 75's could be a steal today.

    PAUL H.
    What a sweet way to get introduced to Momentum. My first trade based on your picks and it a 2X. Thank you!

    NOEL
    “Limit order was set at 1.60 on RIMM so it sold. I may have left some money on the table but you can't go broke making a profit. That was a fun trade. Thank you. Good call. I’ve been watching and trading Rick's advice since March. It’s usually a fun ride, but I give him heck when it's wrong to. :) ”

    CHRISTIAN
    “Your service rocks! I made bank on Dendreon last week! The other thing I have to say is that it took me quite a while to find a REAL options trading service like yours. Most of what’s out there is 99% scam and very sketchy. Momentum Options Trading is the first service I found that I can trust and seriously make money with.”

    JOHN
    “I made $420.00 on ANF in 2 days. Thanks for the trade and updates on getting out of the trade.”

    CHARLES M.
    “I did follow a lot of your trades with 1-2 contracts per trade and YTD I’m up 108%. I try not to follow blindly by not entering all of your trades and sometimes entering the ones you don’t. I entered AIG a few weeks ago against recommendation – that one hurt.”

    BRYAN C.
    “I have been following you for several months and am interested in the new service. I hate to see the free service go away but as they say, “all good things must come to an end”. My ability to join will be greatly influenced by the monthly fee so I’m very curious to see the new prices. Thanks for making April a great month for me and my family.”

    JOHN H.
    “I have really enjoyed the past month since finding your blog. You have made some great calls. I would appreciate info. on the new options mentoring program. Thanks.”

    JEFFREY
    “Hi Rick, I have been following your blog for several months now and I would like to be including on the list for your new service and to receive more information about it. And yes I was a Dendreon winner with your tips. Turned $280 into $7700, and literally saved my butt.”

    ED
    “I made over 6k on your Dendreon trade, and I’m very interested in learning how you pick and trade options. Sign me up.”

    GREG
    “Rick – Wow what a day! I got in at the Dendreon calls at $2.25. Thanks to for your advice. I appreciate that. This company has a lock on this type of therapy and no one else in the world is close. Kind of reminds me of the type of companies that Peter Lynch and Warren Buffet suggest that investments be made in. Companies that can build a moat around their business model, that allows them to charge a premium for their product or service. In other words - a monopoly.”

    KEN
    “Hi Rick, Thank you so much for the Dendreon trade, I made almost $10,000 with that trade with a little over $2,000 investment. You have shown me the power of options trading. Again, thank you so much for all your inputs.”

    GARETT
    “Hi Rick, thanks for the encouragement to play the dendreon calls! did freaking great! Got in the first lot at $1.44 on 3-24-09, sold at $2.45, 70% not bad. Bought it back at $2.30 on 4-7-09 closed out on 4-14-09 for 454% gain! Wow! I love it when that happens. So, thanks the encouragement to get back in when others were saying sell, sell, sell. Keep up the good work.”

    TERENCE
    “Rick – Thanks for Dendreon – it has made all the headlines today! I missed on RIMM earlier, but I’ve been holding onto DNDN calls since 3rd week March. Of course today it all paid off today, as DNDN rocketed up.”

    Jan. 31 2012
    Rick, new member...Studied all current trades, did some chart work,picked ZNGA, PEP, MGM...Sold on Feb. 2 for $3600.00 profit...Cost for 1-year membership to your newsletter was less than $1000.00..All I have to say..Thank you. John H –

    3/18/11
    Rick, I purchased 10 contracts of the Nike March 85 puts Thursday afternoon for $2.00. Thing is, I was upset because the puts went down to $1.60 or so before the market closed. Well, needless to say Nike didn’t impress Wall Street and when I turned on the computer this morning the puts were worth $7.10! Sold them for a $5,100 profit!. Thanks again, you are the MAN. Chuck J-

    2/3/12
    Hi Rick,

    I will start off with a thank you for your time and dedication to all
    the research you and your team commit yourself to. This is not me just being excited about the profits I have accumulated aka (bank) ! You have helped me get back to the passion I had of researching stocks/options. Keith N-

    Hi Rick,

    I want to share my great results on GMCR. Based on your comments on February 15th, I bought 20 options at $0.28. They closed today at $7.00, which is a 2,300% gain. My $560 dollars turned into $14,000 in less than a month. In decades of trading, this is my single best trade ever. Thank you! By the way, the Dow was down 228 points today and I could care less. What a great trade. It proves the amazing power of options. I am so grateful for your service, which calls it straight all the time, your options trading manual, and most of all, your amazing skill
    at finding winning trades. I have attached a copy of the trade from
    my brokerage screen.

Follow us on Twitter